Russell Investments Group’s Third Harmonic Bio THRD Stock Holding History

Russell Investments Group’s Portfolio THRD Stock Details THRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-803	Closed	-$4.32K	–	4257
2025 Q3	$4.32K	Buy	803 +534	+199%	+$2.9K	﹤0.01%	3918
2025 Q2	$1.46K	Buy	269 +246	+1,070%	+$1.23K	﹤0.01%	3624
2025 Q1	$80	Sell	23 -320	-93%	-$1.55K	﹤0.01%	3757
2024 Q4	$3.53K	Hold	343	–	–	﹤0.01%	3351
2024 Q3	$4.65K	Sell	343 -48	-12%	-$595	﹤0.01%	3232
2024 Q2	$5.08K	Buy	391 +48	+14%	+$594	﹤0.01%	3206
2024 Q1	$3.24K	Sell	343 -56	-14%	-$544	﹤0.01%	3007
2023 Q4	$4.38K	Buy	399 +79	+25%	+$626	﹤0.01%	2920
2023 Q3	$2.04K	Buy	+320	New	+$1.96K	﹤0.01%	3260

Other funds holding THRD

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Russell Investments Group's THRD Position: Q4 2025 in Review

Russell Investments Group sold out of Third Harmonic Bio (THRD) in Q4 2025, closing a stake of 803 shares — an estimated $4.32K sold.

Russell Investments Group first reported a position in THRD in Q3 2023 and held it in 9 quarters. The position peaked at $5.08K in Q2 2024. 4 funds tracked by Wall St. Rank hold THRD as of Q4 2025.

Russell Investments Group reported no remaining Third Harmonic Bio position as of Q4 2025 after selling out during the quarter.
Russell Investments Group sold 803 Third Harmonic Bio shares in Q4 2025, an estimated $4.32K.
Russell Investments Group first reported a position in Third Harmonic Bio in Q3 2023 and held it in 9 quarters.
Russell Investments Group's Third Harmonic Bio position peaked at $5.08K in Q2 2024.
4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2025.

Based on Russell Investments Group's 13F filing for Q4 2025, filed 17 Feb 2026.